BE556601A - - Google Patents
Info
- Publication number
- BE556601A BE556601A BE556601DA BE556601A BE 556601 A BE556601 A BE 556601A BE 556601D A BE556601D A BE 556601DA BE 556601 A BE556601 A BE 556601A
- Authority
- BE
- Belgium
- Prior art keywords
- products according
- treatment
- desc
- sodium
- mellate
- Prior art date
Links
- 238000011282 treatment Methods 0.000 claims description 7
- 206010030113 Oedema Diseases 0.000 claims description 3
- 230000018044 dehydration Effects 0.000 claims description 2
- 238000006297 dehydration reaction Methods 0.000 claims description 2
- 238000007920 subcutaneous administration Methods 0.000 claims description 2
- 208000008589 Obesity Diseases 0.000 claims 1
- 230000000747 cardiac effect Effects 0.000 claims 1
- 230000028327 secretion Effects 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- YDSWCNNOKPMOTP-UHFFFAOYSA-N mellitic acid Chemical compound OC(=O)C1=C(C(O)=O)C(C(O)=O)=C(C(O)=O)C(C(O)=O)=C1C(O)=O YDSWCNNOKPMOTP-UHFFFAOYSA-N 0.000 description 11
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 9
- 229910052708 sodium Inorganic materials 0.000 description 9
- 239000011734 sodium Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 5
- 230000001882 diuretic effect Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000010496 Heart Arrest Diseases 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010065768 Visceral oedema Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- -1 cachets Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000035603 choleresis Effects 0.000 description 1
- 239000000731 choleretic agent Substances 0.000 description 1
- 230000001989 choleretic effect Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910001721 mellite Inorganic materials 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 229940083732 mercurial diuretics Drugs 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE556601A true BE556601A (enrdf_load_stackoverflow) |
Family
ID=180316
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE556601D BE556601A (enrdf_load_stackoverflow) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE556601A (enrdf_load_stackoverflow) |
-
0
- BE BE556601D patent/BE556601A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2134316B1 (fr) | Nouvelles compositions cosmetiques et/ ou pharmaceutiques et leurs applications | |
| BE1001209A3 (fr) | Compositions pharmaceutiques contenant un derive de l'acide 3-hydroxybutanoique choisi parmi les oligomeres de cet acide et les esters de cet acide ou de ces oligomeres avec du 1,3-butanediol. | |
| WO2007080515A1 (en) | Thrombosis preventing krill extract | |
| CN108546237A (zh) | 一种以猫豆为原料提取左旋多巴的方法 | |
| FR2630648A1 (enrdf_load_stackoverflow) | ||
| BE556601A (enrdf_load_stackoverflow) | ||
| HU203661B (en) | Process for prodcing pharmaceutical compositions containing unsaturated fatty acids as active components for diminishing glucose-level, for treating diabetes mellitus | |
| FR2989087A1 (fr) | Nouveaux composes oligosaccharides et leur utilisation cosmetique | |
| CN1568929A (zh) | 含有腐植酸的化妆品及腐植酸在化妆品方面的应用 | |
| WO2009007660A9 (fr) | Compositions liquides ou pateuses destinees a l'apport en elements essentiels a la synthese et a la constitution des proteoglycanes, notamment pour le traitement de la degradation du cartilage | |
| JP5426844B2 (ja) | 生体コラーゲン合成促進剤 | |
| KR20110021844A (ko) | 매실나무 추출물의 조성물 제조에서의 응용 | |
| LU87161A1 (fr) | Compositions pharmaceutiques | |
| LU87171A1 (fr) | Compositions cosmetiques regenerant la peau et leur procede de preparation | |
| FR2521430A1 (fr) | Solution aqueuse d'acide ursodesoxycholique a usages therapeutiques, son procede de preparation et application au traitement des lithiases biliaires | |
| JP2012056933A (ja) | エラスチン産生促進剤 | |
| CN106265248A (zh) | 田七提取辅酶q10的工艺及制备护齿护肤产品的方法 | |
| EP1046398B1 (fr) | Préparation d'un médicament contenant des composés polyphénoliques de type catéchique ou flavonyliques d'origine végétale, en particulier pour le traitement des gingivites | |
| JPS5815918A (ja) | アロエ樹液の精製方法 | |
| JP7624190B2 (ja) | 最終糖化生成物（ＡＧＥｓ）分解促進剤 | |
| RU2402345C2 (ru) | ЭКСТРАКТ ИЗ РАСТЕНИЯ Аlhagi pseudalhagi, ФАРМАЦЕВТИЧЕСКАЯ И КОСМЕТИЧЕСКАЯ КОМПОЗИЦИЯ НА ЕГО ОСНОВЕ, СПОСОБЫ СНИЖЕНИЯ СОДЕРЖАНИЯ ХОЛЕСТЕРИНА И ТРИГЛИЦЕРИДОВ В КРОВИ, СНИЖЕНИЯ УРОВНЯ ПРОДУКТОВ ОКИСЛЕНИЯ ЛИПИДОВ, УЛУЧШЕНИЯ МИКРОЦИРКУЛЯЦИИ, АНТИОКСИДАНТНЫХ СВОЙСТВ, УЛУЧШЕНИЯ СОСТОЯНИЯ КОЖНЫХ ПОКРОВОВ, СТИМУЛИРОВАНИЯ ОБРАЗОВАНИЯ КОЛЛАГЕНА, РАНОЗАЖИВЛЕНИЯ И СНИЖЕНИЯ ВОСПАЛЕНИЯ | |
| US20250144122A1 (en) | Scent-Changing Ointment & Method of Making The Same | |
| WO2019080983A1 (fr) | Nouvelle formulation a base de chitosane et son procede de preparation. | |
| US20060153939A1 (en) | Method of obtaining and treating compounds from ozonized unsaturated vegetable oils for pharmaceutical compositions for medical and veterinary use | |
| CN103251672B (zh) | 一种山葵口腔喷雾剂及其制备方法 |